Related Experiment Video

Updated: May 25, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Headway in resistance to endocrine therapy in breast cancer

Yali Xu1, Qiang Sun

  • 1Department of Breast Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, PR China.

Journal of Thoracic Disease
|January 21, 2012
PubMed

Insights

Endocrine resistance in ERα(+) breast cancer is a major challenge. Key mechanisms involve estrogen receptor phosphorylation, SRC expression, and ErbB/MAPK pathway activation, requiring further research for clinical solutions.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Endocrine therapy resistance is a significant clinical problem for estrogen receptor-alpha positive (ERα(+)) breast cancer patients.
  • Current research primarily utilizes cell lines and animal models to investigate endocrine resistance mechanisms.

Purpose of the Study:

  • To summarize the key molecular mechanisms driving endocrine resistance in ERα(+) breast cancer.
  • To identify promising therapeutic strategies for overcoming endocrine resistance.

Main Methods:

  • Literature review and analysis of existing research on endocrine resistance in breast cancer.
  • Identification of key molecular pathways and targets implicated in resistance.

Main Results:

  • Three primary mechanisms identified: estrogen receptor (ER) phosphorylation, SRC (a non-receptor tyrosine kinase) high expression, and ErbB/MAPK (a cell signaling pathway) high activation.
  • Two promising therapeutic avenues: restoration of ER expression and development of inhibitors targeting key biological molecules.

Conclusions:

  • Understanding ER phosphorylation, SRC, and ErbB/MAPK pathways is crucial for addressing endocrine resistance.
  • Further investigation into these mechanisms and potential therapeutic targets is necessary to guide clinical practice and improve patient outcomes.
Keywords:
AEs/AIsErbB /MAPKSRCbreast cancerendocrine resistance

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...